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Abstract Marine viruses are ubiquitous, extremely diverse, and outnumber any form of life in
the sea. Despite their ecological importance, viruses in marine environments have been largely
ignored by the academic community, and only those that have caused substantial economic
losses have received more attention. Fortunately, our current understanding on marine viruses
has advanced considerably during the last decades. These advances have opened new and
exciting research opportunities as several unique structural and genetic characteristics of
marine viruses have shown to possess an immense potential for various biotechnological
applications. Here, a condensed overview of the possibilities of using the enormous potential
offered by marine viruses to develop innovative products in industries as pharmaceuticals,
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environmental remediation, cosmetics, material sciences, and several others, is presented. The
importance of marine viruses to biotechnology should not be underestimated.
Keywords Biotechnology.Marine viruses . Remediation . Cosmetics . Aquaculture . Delivery
vehicles
Introduction
Over the last 120 years, viruses have been recognized as causal agents of infectious illness and
death, and consequently its study has become a major research topic, as confirmed by the
number of scientific articles published during the last 50 years (Fig. 1a). However, research
conducted in the last years has dramatically broadened our knowledge and has opened new
perspectives in our view on viruses in basic and, particularly, applied disciplines. The latter is
documented in the remarkable increase in the number of scientific publications dealing with
the application of viruses in biotechnology (Fig. 1b).
Since their discovery at the end of the 1970s [1], marine viruses have attracted considerable
attention as well, mainly because of their economic and ecological negative impact on both
farmed and wild marine species (Fig. 1c). The ability of marine viruses to infect a broad range
of evolutionary divergent groups of marine organisms as bacteria, protists, molluscs, crusta-
ceans, cnidarians, reptiles, fishes, and mammals, has been largely documented over the years
[2], and actually, an ample literature exists on this topic. However, despite a number of studies
characterizing certain unique properties of interest for both basic research and industrial
applications, these viruses have remained largely unexplored (Fig. 1d). This is surprising as
Fig. 1 Total number of peer-reviewed articles published until 2012, containing the terms: viruses (a), viruses
AND biotechnology (b), marine viruses (c), and marine viruses AND biotechnology (d). The PubMed database
was used to search the peer-reviewed articles containing the above-mentioned subjects from 1963 (for viruses),
1982 (for viruses AND biotechnology), 1982 (for marine viruses), and 1991 (for marine viruses AND biotech-
nology) to 2012
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marine viruses represent the most abundant biological entities inhabiting the world’s oceans
(Fig. 2) and are recognized as ecologically important components of the marine environment
[3–5] as they accelerate the transformation of particulate nutrients to a dissolved available
state, for reutilization by microbial communities (Fig. 3). Moreover, marine viruses are now
considered as the greatest reservoir of unexplored genetic diversity on our planet [5]. In this
context, it must be stressed that the majority of the genetic properties of marine viruses
(encoding an enormous supply of biochemical and physiological information) are functionally
unknown [6], positioning marine viruses as suitable sources for the development of new and
versatile tools for biotechnology.
Research on the potential applications of marine viruses in various biotechnological
processes is currently a fascinating emerging topic that is remarkably understudied, and the
gap between basic research on marine viruses and the applied side of it is rapidly widening.
Recent findings, however, have exhibited a wide spectrum of novel characteristics in marine
viruses that may provide major biotechnology breakthroughs and possibilities in a number of
different fields like medicine, material science, and cosmetics. Here, we draw attention toward
marine viruses as a novel source for biotechnological products, and we briefly speculate on the
realistic potential for their application.
Marine Viruses and Environmental Remediation
Over-enrichment of aquatic systems with nutrients, principally phosphorus (P), results in a
problematic condition known as eutrophication [7, 8], a widespread and growing problem in
which water quality is compromised [9]. Recently, the concept of planetary boundaries was
proposed to define the human-determined acceptable levels of key global variables [10, 11]. In
the case of P, it has been found that the discharge levels of P from freshwater into the oceans
already exceed the proposed boundary of ten times the pre-industrial level [12]. Phosphorus
can reach oceanic waters through the disposal of wastewaters or as a result of runoff and
leaching. It must be underlined that the use of P fertilizers has declined drastically across
Europe and in other developed nations in the last 20 years, in contrast to the increasing demand
for P fertilizers in developing countries (Fig. 4). On the other hand, large amounts of
wastewaters are generated in modern industrial societies and must be treated prior to disposal
into waterways. Recent estimates suggest that urban residents discharge 2–3 g P per capita per
Fig. 2 Relative estimated abundance of protists, prokaryotes, (bacteria and archea) and viruses. Viruses are
known to be the most abundant biological entities in the oceans, exceeding the abundance of bacteria and archaea
by ~15-fold. Marine viruses comprise approximately 94 % of the nucleic acid-containing particles in the oceans,
while prokaryotes and protists represent only a 5 and 1 %, respectively. Similarly, the number of viruses in marine
sediments always exceeds the total cell counts [63]. The extensive number of viruses in marine sediments
highlights their impact as a controlling factor for prokaryotic mortality. Modified from [64]
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day from households [13], and that the total amount of phosphates discharged in urban
wastewaters in the European Union almost reaches 1,145,000 t (in P2O5 equivalent) per year.
Furthermore, anaerobic treatment of wastewater releases large amounts of P, which has been
implicated in cases of eutrophication of water bodies [14]. Therefore, P must be removed from
wastewater effluents before it is returned to the environment. The current technologies to
reduce P levels in wastewaters include chemical precipitation or physical and biological
Fig. 3 Viruses are a highly important force driving the biogeochemical cycles in the ocean. Viral lysis influences
the flow of carbon and nutrients from phytoplankton and bacteria to higher trophic levels in a quantitatively
significant amount. Furthermore, the effect viral shunt allows the carbon from infected cells to remain as
dissolved organic matter near the ocean surface, where they are assimilated by heterotrophic bacteria and
released into the environment as recycled inorganic nutrients that are used again by phytoplankton. Modified
from [64]
Fig. 4 World phosphorus fertilizer consumption. The amount of phosphorus fertilized consumed by Europe and
other developed countries (black) decreased significantly between 1989 and 1994, while in developing countries
(medium gray), the demand for P fertilizers has increased constantly. World total consumption (ligh gray) has
remained relatively steady since 1981 to date. Data obtained from the International Fertilizer Industry Association
(http://www.fertilizer.org/ifa/ifadata/search)
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methods. Chemical precipitation of P is accomplished by the addition of a coagulant, typically
an iron or aluminum salt, with high efficiency and simple operation conditions [15], but this
process is highly expensive [16]. The biological process, known as enhanced biological
phosphorus removal (EBPR), depends on microorganisms that accumulate large quantities
of P (as polyphosphate) intracellularly [17, 18]. However, this system often deteriorates at low
chemical oxygen demand (COD) and under aerated conditions [19, 20].
An efficient alternative in P-remediation might be provided by marine phages (including
cyanophages), which are the most abundant and highly diverse, as well as largely
uncharacterized, component of marine viral assemblages [21]. Several metagenomic-based
approaches have led to the discovery of a large set of unrecognized open reading frames
(ORFs) and a wide variety of phage-encoded genes, traditionally considered as exclusively
associated to cellular genomes, involved in central metabolic pathways and key regulatory
mechanisms of their hosts [22, 23]. A recent study revealed that the genomes of two phages
(cyanomyophages P-SSM2 and P-SSM4) that infect the ubiquitous marine cyanobacteria
Prochlorococcus marinus contain a gene encoding for a high-affinity phosphate-binding
protein (pstS) [24]. Phosphorus is an obligate requirement for the growth of cyanobacteria,
but its bioavailability in environments with low absolute concentrations of nutrients is scarce.
Furthermore, significant amounts of P are also required during the replication of the
cyanophage genome. Thus, a significant increase in the expression of pstS contributes to a
rapid P uptake in cyanophage-infected P-starved host cells, contributing to initiate the lytic
cycle under favorable conditions. It is obvious that these phages could gain a significant fitness
advantage by increasing host P acquisition in P-limited environments [25]. Because of its high
affinity for P, this protein may contribute to applications in the area of environmental
biotechnology.
A new approach for removing P from wastewaters is based on the expression of a
heterologous phosphate-binding protein (PBP) on the surface of recombinant bacteria, a
process called “bacterial surface display.” In a recent study, the Escherichia coli K12 PBP
was expressed and localized on the surface of an engineered strain of Pseudomonas putida.
The phosphate biosorption capacity was high and reached 288 mg L−1 per day by 0.45 mg of
cells (dry weight). Furthermore, this P-absorption capacity was retained at an appreciable level
even in heat-killed cells [26]. Accordingly, the expression of the viral high-affinity phosphate-
binding protein pstS on the surface of P. putida, a bacterial system that remains viable under
low-COD conditions, may become a highly attractive and promising solution for wastewater
treatment.
Marine Viruses and Cosmetics
Another potential application of marine viruses is in the cosmetics industry. Emiliania huxleyi
(Fig. 5), a worldwide distributed unicellular algal species, is capable of forming vast blooms in
the open ocean, which can cover areal extents of more than 100,000 km2. During the last
decade it was demonstrated that a virus, designated as EhV, was able to infect and replicate
efficiently within E. huxleyi cells, and subsequently the full viral genome sequence of the strain
EhV-86 was published [27, 28]. A unique feature of the EhV-86 genome is that it contains a
cluster of at least seven genes encoding key components of sphingolipid biosynthesis, leading
to the formation of ceramide, which seems to be expressed to enrich cell membranes and
modulate the entry and release of the viral particles, controlling thus a successful infection [28,
29]. These viral genes for the biosynthesis of sphingolipids are the first found in a viral
genome, and the evidence suggests that they were horizontally acquired from its host in a
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series of separate transfer events, conferring a selective advantage and increasing the fitness of
this virus [30].
The ceramides, amides of fatty acids with hydroxylated long chain amines (Fig. 6), are key
intermediate products in the biosynthesis and catabolism of various sphingolipids. Ceramides
have been associated in the regulation of critical processes as aging, cell differentiation,
apoptosis, and cell cycle arrest [31], and as key structural lipids of skin, hair, and nails of
humans and animals, and due to its major role as an effective epidermal barrier against water
loss [32], there has been considerable interest in these compounds as active components in the
cosmetic industry [33]. Even if synthetic ceramides are now commonly used in the preparation
of cosmetic products, most of these biomolecules currently used are obtained from natural
sources such as bovine brain, porcine epidermal tissues, eggs, blood cells, plants, and yeast
[34] (Table 1). However, these sources may cause health problems due to the potential
contamination with pathogen agents as bacteria and bovine spongiform encephalopathy.
Furthermore, ceramide extraction from these sources is expensive and affords low yields.
Thus, the expression and production of ceramides by EhV-86 may represent a promising
source of natural ceramides for use in medicines and cosmetics.
Marine Viruses in Aquaculture: the Trojan Horse
Various forms of viral diseases have been reported to infect shrimp and several other
crustaceans. Among the most lethal viruses infecting shrimp, one deserves particular attention
Fig. 5 A scanning electron
microscope image of a Emiliania
huxleyi cell. The scale bar
represents 1 μm. Kindly
provided by Dr. Jeremy R.
Young (Earth Sciences,
University College London)
Fig. 6 Representative chemical
structure of ceramides
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since outbreaks of this disease has caused social, economic, and ecological adverse impacts on
many countries: the Penaeus stylirostris densovirus (PstDNV, also known as IHHNV). The
PstDNV, a highly prevalent and widely distributed shrimp virus, may cause high mortality
rates of above 90 % among juvenile specimens of the blue shrimp P. stylirostris [35], while in
the whiteleg shrimp Penaeus vannamei it has been associated with runt deformity syndrome
(RDS), causing significant reduction on the growth rate and cuticular deformities as bent
rostrum, blistered cuticle, bent telson, abdominal anomalies, and curly antennae [36].
The PstDNV (Fig. 7), classified as a member of the family Parvoviridae, is the smallest of
the known penaeid shrimp viruses (the non-enveloped particles have a diameter of 22 nm).
The typical PstDNV genome is a linear non-segmented single-stranded DNA of 3.9 Kb, and is
composed by three large overlapping open reading frames (ORFs): the left ORF, the right
ORF, and the middle ORF (and a potential domain of 704 nt, referred as small ORF, found on
the complementary DNA strand) (Fig. 8). By analogy to the right ORF sequence from other
parvoviruses, it has been suggested that it encodes the capsid protein (CP) [37]. The full-length
coding region of the PstDNV-CP gene was recombinantly expressed in E. coli, and the
obtained capsid protein self-assembled spontaneously into virus-like particles (VLPs) with
Table 1 Natural and synthetic sources of ceramides
Source
Microorganisms • Yeast extracts
• Expensive
Plants • Soy bean extracts, wheat, rice seeds, spinach
• Small amounts
Animals • Bovine brain, spinal cord, egg, skin
• Potential risk of contamination by pathogen agents (i. e., BSE), expensive
Chemical synthesis • Various structures, improper stereochemistry, undesired residual chemicals,
large amount of by-products, environmental impact
Fig. 7 A high-resolution three-dimensional structure of the recombinant PstDNV capsid showing the prominent
surface features. Kindly provided by Dr. Michael G. Rossmann (Hockmeyer Hall of Structural Biology, Purdue
University)
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homogeneous size and a similar shape to those observed in native PstDNV particles. Further-
more, it was found that the recombinant PstDNV-VLPs are able to encapsidate substantial
amounts of nucleic acids, mainly RNAwith a predominant size of 0.5 kb and are also able to
efficiently bind and enter into primary hemocytes of shrimp [38].
Currently, there are no effective approaches to prevent or reduce the deleterious impact of
this viral pathogen over shrimp populations, and only few studies have been conducted to
evaluate potential antiviral strategies against it. A recent report revealed that the replication of
the virus was effectively reduced by the introduction of double-stranded RNA interference
(dsRNAi) constructs corresponding to the PstDNV-CP in experimentally infected house
crickets (Acheta domesticus). This suggests that the administration of PstDNV-specific dsRNA
may provide a useful alternative against this virus in crustaceans [39]. Similar results have
been obtained in shrimp treated with dsRNA designed to target virus-specific sequences.
However, it must be underlined that even though the use of dsRNA to provide sequence-
dependent protection to shrimp against specific viruses seems promising, the major challenge
to turn it into an effective therapeutic strategy is the delivery system [40]: The dsRNA is
regularly administered by intramuscular injection, which would become a physically demand-
ing task for the millions of individuals in a shrimp farm, and the necessity to design an
adequate delivery system to overcome this limitation is fundamental. Thus, the PstDNV-VLPs
may potentially act as an appropriate vehicle system to deliver dsRNA. Previous studies have
demonstrated the use of VLPs to deliver RNAi successfully as a therapeutic approach against
viral diseases. Recently, a report showed that the recombinant JC virus (JCV, a human
polyomavirus) major capsid protein is a competent vector to deliver RNAi for gene therapy
purposes [41].
Using Marine Viruses Genetic Properties to Treat Diseases
As a rough approximation, after infection of susceptible cells, viral transcription proceeds
through an ordered cascade of events, which can be broadly divided into three sequential
phases of expression: immediate-early (IE), early (E) and late (L) [42]. Products of IE genes
are expressed relying primarily on host proteins and factors, and its transcription activates the
expression of viral E and L genes, altering thus the functions of the host immune defense. Just
as several other viruses, the white spot syndrome virus (WSSV), perhaps the most devastating
virus affecting the shrimp aquaculture industry, transcribes its genome in such temporally
defined manner, and to date 18 WSSV IE genes have been identified [43, 44]. Although the
functions of most of the corresponding WSSV IE proteins remain unknown, many IE genes of
other viruses encode multifunctional transcriptional regulators that may modulate the subse-
quent replicative events occurring during infection. A recent study has demonstrated a high
promoter activity of the WSSV IE gene ie1 in Sf9 insect cells [44]. Its promoter activity for
gene expression in insect cells is stronger than that of the cytomegalovirus (CMV) IE
promoter, which is widely used as a strong and constitutively active promoter [45, 46].
Fig. 8 Schematic representation of the genome organization of the Penaeus stylirostris densovirus (PstDNV,
also known as IHHNV). The three open reading frames (ORFs; left ORF, middle ORF, and right ORF) are
indicated by boxes. The predicted donor (D1) and acceptors (A1, A2, and A3) sites are represented by black
triangles. The locations of the promoters (P2, P11, and P61) are represented by thin boxes. Modified from [36]
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The unprecedented worldwide spread of highly pathogenic avian influenza viruses of the
H5N1 strain is currently considered a global health concern that has provoked significant
mortalities in poultry and wild bird’s populations. Furthermore, it has caused human infections
and mortality since 1997, when it first proved lethal in humans in an outbreak in Hong Kong.
Vaccination of poultry has been recognized as effective in preventing virus introductions and
limiting the size of outbreaks. However, the production of an inactivated influence vaccine
requires the use of large amounts of embryonated eggs from a certified source, high-level
biosecurity facilities, adequately trained personnel, and substantial financial resources. An attrac-
tive alternative is the use of recombinant hemagglutinin (HA) protein-based subunit vaccines [47].
The viral protein HA facilitates the entry of influenza viruses into host cells by binding to
cell receptors via sialic acid (SA)-linked glycoprotein [48], and it also induces the process of
membrane fusion [49]. Since HA is the major antigen on the surface of influenza viruses [50],
it serves as the primary target for neutralizing antibodies.
Baculoviruses have been widely used since the early 1980s as an efficient vector system for
the safe and abundant expression of recombinant proteins [51], as the post-translational
modifications and protein folding systems are similar to those of mammals [52]. Furthermore,
a number of genetic modifications, as the insertion of several types of promoters, have been
incorporated into baculoviral vectors to enhance the expression of heterologous proteins in
both insect and mammalian cells. Thus, HA from the H5N1 strain has been efficiently
expressed in baculovirus under the control of the WSSV ie1 promoter without disrupting its
authentic cleavage, hemagglutination activity, and immunogenicity, and it could be delivered
into host cells to elicit a robust and specific long-term immune response. Furthermore, the
WSSV ie1 was more efficient than the CMV IE promoter to express H5 hemagglutinin from
avian influenza virus in baculovirus, providing a more powerful alternative to the preceding
methods of vaccine production [45].
Viruses: the Unseen Technology
Nanotechnology has quietly, but profoundly, permeated all aspects of our daily lives. It
involves the design, production or manipulation, and application of materials or structures
within the size range of approximately 1–100 nm in length. In this scale, the physical and
chemical properties of matter differ significantly from those of macroscale materials composed
of the same constituent [53–55]. Investment in nanotechnology has drastically increased in the
past decade, and numerous companies in a variety of areas as information, communication
technologies, materials, drug development and delivery, health care, and medicine diagnostics,
are already developing products that are reaching the market successfully. Global sales
revenues for nanotechnology products have been estimated at ~US$16 billion in 2012 and
US$37.3 billion in 2017, an expected compounded annual growth rate of 18.6 % [56].
Various relevant features, as the self-assembly of their capsid, have contributed to the
increasing interest and appreciation from the research community for viruses as biomaterials to
develop functional materials, systems, and devices with nanoscale dimensions. Thus, as all
viral capsids are assembled from virus-coded protein subunits, they can be modified through
genetic engineering, allowing the incorporation of designed functionalities. Furthermore, the
capsid of a number of viruses can be disassembled and reassembled under different conditions
[57], which provide an opportunity to use viruses as nanocontainers [58].
An additional attribute of marine viruses that may also be relevant for nanotechnology is its
remarkable morphological diversity of shapes and sizes. Virion morphologies include spher-
ical, icosahedral, filamentous, rod-shaped, spindle-shaped, and tailed shapes. This variety has
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promoted the development of nanoparticles of different designs as drug carriers. It is now well
recognized that the size, shape, and surface chemistry of a nanoparticle has a significant impact
on their performance [59], and an arsenal of shapes may contribute to the development of next-
generation biomaterials and devises for a wide variety of applications.
Concluding Remarks and Prospects
In contrast to other marine microorganisms, viruses that inhabit oceans and seas have not been
explored for biotechnological applications. This review has depicted some novel features of
marine viruses that may be translated into practical applications in health care, the environ-
ment, and industry. Of course, curiosity, intuition, integrity, and the analytical ability to
recognize and connect multiple pieces of information will play key roles in the process of
design and development of new and highly innovative biotechnological products. The above-
mentioned examples are only a few of the possible biotechnological applications of marine
viruses that can be exploited commercially. However, applications of marine viruses are still
limited by our limited understanding of viral diversity, host-virus interactions, virulence,
emergence, transmissibility, viral dynamics, biochemical structure, and evolution. Despite
the fact that over the last decade there have been substantial advances in the understanding
of the biology of marine viruses, a more thorough knowledge of the genomes and
transcriptomes composing viral communities inhabiting the oceans will be required to provide
a wider spectrum of future biotechnological applications.
It is worth mentioning that the use of marine viruses in biotechnology depends largely on
the potential health and environmental risks associated with them. There is no doubt that
modern biotechnology, as any new technology, is surrounded by benefits and risks for society,
and any new product derived from biotechnology must have a favorable benefit-risk balance.
Of course, to exploit the full potential of viruses as valuable tools for biotechnology, biosafety
issues should be considered and discussed, information on areas of risk should be provided to
aid in the avoidance of these potential risks, and appropriate safety policies must be suggested
to ensure the accurate diagnosis and proper handling of the potential risks of marine viruses.
However, some control strategies to avoid these risks, as the methodology to construct
replication-defective or movement-defective viruses, already exist [60–62].
In addition, much of the knowledge about marine viruses has been obtained as a conse-
quence of the economic and social impact of a limited number of viral diseases affecting
commercially important species, such as fishes, oysters, and shrimp. We can visualize that due
to its vast diversity and genetic richness, marine viruses offer a seductive notion of a
potentially vast, unexploited, and beneficial resource. Of course, it may not be surprising,
given the recent findings that the genomes of many marine viruses contain putative genes
encoding proteins with unknown function, to witness an exponential rise in biotechnological
interest for marine viruses; particularly once the biological role of those proteins becomes
elucidated. As our scientific knowledge on marine viruses progresses, we would be witnessing
“the viruscence of biotechnology.”
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